Infarmed has ordered the suspension of marketing and withdrawal from the market of two creams containing cannabidiol, the use of which is banned in cosmetic products, the medicines authority has announced.
In information available today on its website, Infarmed explains that the decision was based on a complaint received regarding Cannabiron CBD creams, from Dietmed, and Good Cannabis, from Vitaceutics.
The National Authority for Medicines and Health Products recalls the 2022 circular on the use of cannabis and its derivatives in cosmetic products.
It also explains that the creams in question contain cannabidiol, which is obtained from extracts or tinctures of cannabis or its resin and is not permitted in cosmetic products.
“Entities that have these products should not make them available” and consumers who have these products “should not use them”, recommends Infarmed.